the deal that was signed between the university of oxford and astra zeneca was intended to supply factsin a to go play will scale. the deal that we have with us to senate means that the university doesn't profit from the sale of this vaccine. while the pandemic is happening and that we will never profit from this vaccine, from the sale of it to, you know, middle income countries because we wanted you want this to be a vaccine for the whole world. there was kitty, you were speaking with me earlier. if you o.p.'s government is warning residents of the embattled, the region that anything can happen as the clock ticks down on its alter, made of the government has given forces until wednesday to lay down their arms or face an assault on the regional capital. but the people's liberation front has vowed to keep on fighting. the un fears 200000 people could flee to neighboring sudan because of the conflict. ethiopian forces pushed further into the to grow region. the advance has not been a challenge as the degree of battle on the roadside attests. but the government and addis ababa is confident

so she, professor of oxford university's jenner institute, the developed this latest vaccine this year. we appreciate your time and congratulations again. thank you very much. turkey has prevented a search operation by the german navy of a cargo ship suspected of smuggling arms into libya. the german frigate hamburg intercepted the turkish vessel in the mediterranean on sunday night. the german worship is part of a european union naval mission to stop arms reaching libya, german soldiers boarded the cargo ship, but had to abort their search after the turkish government protested to the e.u. commission. i for more now i'm joined by our political correspondent hans braun. good evening to you, hans. so what more can you tell us about this incident? what happened is that this german frigate to inform the ship concerned that they want to search it that stopped the ship and then gave it a couple of allas for the facts to sink in. as it were, once this waiting period had paused, german marines entered the ship and stopped at this search. until that point, everything went reasonably well and t

biontechave announced their experimental covid-19 vaccine is over 90% one professor at the university of oxfordays this news had -- one per -- 90%. one professor the oxford -- university of oxford said this news has made him smile year-to-year. >> in the words of pfizer, a great day for humanity. >> we understand the hoax of billions of people and millions of businesses, and hundreds of governments fell on our shoulders. now we can see light at the end of the tunnel. >> the news has sparked hopeful but cautious optimism from leaders across the globe. in a tweet, the world health organization said the development was encouraging, and paste an unprecedented scientific -- praise than unprecedented scientific collaboration and innovation. the director general repeated the warning against vaccine nationalism. tedros: the world has come together like never before to make sure these life-saving tools are advocated fairly. not become one more reason why some people are left behind. >> the european union also welcomes the vaccine breakthrough. european commission president ursula von der leyen said they

university of oxford.esearchers took a common cold virus that infects chimpanzees, genetically engineering it to trick the human body thinking it'd has been infected with the virus that causes covid-19 and producing an immune response. over 24,000 volunteers took part in the clinical trials in the u.k., brazil, and south africa. the late-stage trials sw the vaccine is better at preventing hospitalizations and severe cases of covid-19 than the mrna vaccines developed by moderna and pfizer-biontch. >> people are not getting sick. even if you were to get you would have mild symptoms and that is important to keep hospital beds free, and people will not be dying from this virus. >> that is not the only advantage. it can detect abnormal fridge temperatures, making it easy to distribute, especially in developing countries. it can also be manufactured at scale -- meaning it can be produced in much greater quantities and much lower -- at much lower costs than its rivals. >> i think it will be truly global vaccine i

if more, i'm joined now by katie europe, she's an associate professor of oxford university's jenner institute that developed the vaccine is you work as an immunologist. and one of the investigators involved in the trials of this vaccine this year is going to have you on the show. congratulations are in order. you must be excited and delighted. yes, we are delighted with these results. it's been a very long, difficult, 9 months for us all on the team here in oxford say without c.t. like you were these results today. i mean 9 months, not even a year to develop this. that that's quite an achievement. has that. do you think has that set in with you or your colleagues of how quickly you've been able to get to this stage? well, we've been preparing for an event like this at the general institute for several years now. and if i was, technology has been in development value for decades, and we've always been working on how we could use a vaccine against an unknown pathogen and we call it disease x. . but we've been planning for this kind of eventuality for several years now. so working on the technol

astrazeneca says its vaccine candidate developed together with the university of oxford can be up to effective against covid-19 a second regimen gave an efficacy rate of 62% meaning together both dosing regimens have an average efficacy of 70%. they reported no serious safety concerns in its trial and no participants were hospitalized the vaccine candidate can also be stored at normal refrigerated conditions between 2 and 8 degrees celsius. so, joumanna, the key for investors, the key numbers from today's results is 70% that's the average efficacy of this vaccine they did trial the vaccine with two different dosing regimens and one of those dosing regimens yielded 90% efficacy rate. the bulk of the study participants took the regimen where the efficacy rate showed a 62%. so we're looking at 70%. i think the key question now is how this compares to pfizer and moderna and whether we should view this 70% a good result. the answer is yes, this is a solid result from astrazeneca. the fda says they need a vaccine to be 50% effective or higher. clearly this is firmly in that zone when it com

the way we have been able to investigate this is to a big collaboration between the university of oxfordiversity hospitals, where we follow what has happened to over 12,000 health care workers —— oxford university. over the last six months. in april we started to measure antibody levels in the numbers of staff and we can use this to work out who would been affected before and who hadn't been. and then we can see whether what happened to the two groups over the time differed. in what we found was that in the group who have been affected before and had antibodies, that actually none of them over 1200 of them that we investigated them, none of them develop a further symptomatic infection. where as in the 11,000 or so people who didn't have antibodies, 89 of them went on to get another first infection. what we can take from this is if you have been affected before, we can measure antibodies can be a chance of being affected again is low. here in the uk, the prime minister borisjohnson has expressed full confidence in his home secretary, priti patel — despite a report into claims of bullying

stories this hour that have been promising results from a coronavirus vaccine developed by the university of oxford and astra zeneca. the latest phase 2 findings show a strong immune response has been triggered in people over 70 years old. meanwhile, infections across africa have surpassed 2000000 of low rates of testing means the caseload is thought to be much higher. united nations says 30000 people have not crossed into sit down from northern ethiopia. they're fleeing ongoing violence between federal government forces and local forces in that scene. gray reach. pakistan's prime minister is in afghanistan for talks with president hamid in cimarron khan's 1st visit to the country. it comes as peace talks between afghanistan and the taliban have stalled. and there's been ongoing violence between afghan forces and the taliban is following the story from islamabad. the fact remains that the election that of running a star on a budget on a prime minister all is a great thing for the time when he had vested nation, saying that he would be going to afghanistan and a priority to the wave of stagnation be

the university of oxford say their joint they develop job is 70 percent effective. it's also said to be affordable and easy to store. we'll bring you the market reaction. also coming up, small retailers in france are struggling during lockdown. now online giants, including on its own, are offering to show some solid hours. see all the farmers in iraq are calling it a bumper harvest, but covert 19 restrictions are approaching. this is the business i'm capered from. welcome along. a covert 19 vaccine developed by astra zeneca. the university of oxford has shown to be 70 percent effective in a large scale clinical trial. the vaccine was the most effective of up to 90 percent when patients were 1st given a high dose, then a full one a month later. astra zeneca said it could begin distribution by the end of the year if it gets regulatory approval. unlike the biotech pfizer vaccine, this one can be stored in a fridge instead of needing an ultra cold freezer. let's talk to the business correspondent in new york against this sounds like incredibly good news, but after that,

the vaccines being developed with oxford university and it's in the final stages of human trials. now in the last 10 days, 2 other drug makers, pfizer and madonna, reported their back scenes are more than 90 percent effective in late stage trials . well, globally cases have surpassed 56000000. there have been more than 1300000 deaths worldwide. 250000 of those in the u.s. making it the worst affected country by far or charlie rangel has been following developments from london. just published its phase 2 results, which were based on a group of $560.00 volunteers. is it not? it's phase 3 results which will be coming in the next few weeks. but the initial results showed that this vaccine is generating a strong immune response, an adult over 1617. this is a very crucial age group because vaccines don't tend to work as well in older people because as we get older. 'd our immune systems deteriorate. this vaccine is different from the other 2 that we've been reporting on because it is made from a weakened version of the common cold virus found in chimpanzees, which is then modified to ma

the university of oxford has shown to be 70 percent effective in a large scale clinical trial. the vaccine was most effective at a rate of up to 90 percent when patients were 1st given a hot dose, then a full dose a month later. astra zeneca said it could begin distribution by the end of the year if it gets regulatory approval. unlike the buy on tag pfizer vaccine, this one can be stored in a fridge instead of needing an ultra cold freezer. here's how our financial correspondent, pandi described market reaction to the news. the market. this announcement from the oxford university. that's because this vaccine is being seen as the big court for any normalcy due to turn around the would. this vaccine is cheaper, it is easier to distribute and store. and also this is a vaccine that has actually seen the maximum interest so far. scored the maximum number all for advance, including one from the vaccine alliance, which is looking to distribute the vaccines in africa and other poorer countries. pandey in frankfurt for us now over the weekend leaders of the world's richest nations, conve

there's been promising results from the current virus vaccine developed by the university of oxford and astra zeneca. the latest phase to finding show a strong immune response was triggered in those aged over 70. donald trump's legal team is again making allegations of voter fraud without presenting any evidence. his lawyer, rudy giuliani is speaking live at the republican.

a covert 19 vaccine from astra zeneca and the university of oxford has 70 percent effective. average, in a large scale clinical trial. the vaccine was most effective at a rate of up to 90 percent when patients were given a half dose, then a full dose a month later, esther seneca said it can begin to distribute by year end pending regulatory approval. the vaccine can be stored in a fridge instead of an ultra cold freezer, like the vaccine submitted for u.s. regulatory approval last week by pfizer, and germany's biotech. let's bring in w. financial correspondent. in frankfurt more, i should turn a 3rd problem soon. vaccine candidate by western company markets are liking it. i reckon. yeah, absolutely. yes, the markets have cheered this development across europe and asia. and here behind me, if you see dax is up, even it's the same story in london and paris. actually the ox or the vaccine is the big hole. as you mentioned, it's cheap, it's easy to distribute it. this is the vaccine, that's a maximum interest has been seeing the maximum interest from developing countries. it has

drugmaker astra, zeneca and the university of oxford in the u.k. say their corner of virus vaccine could be up to 90 percent effective in preventing cope with 19 or researchers say the vaccine was most effective when patients will 1st given a half dose, followed by a full those one months later, crucially, the shots can be kept refrigerator temperatures and is not required. extreme cold storage, like other recently announced racks in his affairs, and i says it will have 200000000 doses available by the end of the year encouraging development there. let's get you more on mohamed, were near joins me now. he's of all interest and vaccine expert at lancaster university in the u.k. . very encouraging news there. dr. murray, near what distinguishes this vaccine from rival vaccines. well, thank you very much for having me on the show. this is circularity, encroaching on more vaccines. we would have acted, would you think of that of women having choices, but particularly speaking about the last as any talks for the vaccine, it has certainly i want it is as

top stories there have been promising results from a coronavirus vaccine developed by the university of oxford and astra zeneca, the chemical company. the latest phase 2 findings show a strong immune response has been triggered in people over 70 has more from london . the initial results showed that this vaccine is generating a strong immune response in adults over 1617. this is a very crucial age group because vaccines don't tend to work as well in older people because as we get older, our immune systems deteriorate. this vaccine is different from the other 2 that we've been reporting on because it is made from a weakened version of the common cold virus found in chimpanzees, which is then modified to make sure that it cannot grow in humans is given in 2 doses. and so far is reporting and 99 percent efficacy rate. all participants have been gente generating neutralizing antibodies that is knocking out the virus in their bloodstream with no reported side effects. meanwhile, infections across africa have risen above 2000000, the world health organization. as one, the continent is moving towards

they've been promising results from a coronavirus vaccine developed by the university of oxford in astra zeneca. the latest phase 2 findings show a strong immune response westray, given those age over 17. meanwhile, the number of quoted 900 french and the cost africa has surpassed 2000000, but no rates of testing means the case notice thought to be much higher across the continent. and at least 16 people have been killed in uganda. jury protests launched by the arrest of opposition leader, bobby, why security forces shot at crowds as they demonstrated after wine was detained, at least 350 people have been arrested since wednesday. now michael has become the 1st us secretary of state to visit an illegal settlement in the occupied west bank from there to the golan heights, also becoming the 1st top u.s. official to visit there. since israel took control of the territory in 1967, pales in israel as part of a 10 day tour of the middle east and europe. earlier he met with prime minister benjamin netanyahu and said settlements can be novel and proper. bail also says the u.s. will be stepping u

astrazeneca and the university of oxford the latest to deliver positive vaccine developments. shares are lower today as analyst question some of the findings, although there is an outperform on the stock. we will speak with matthew harrison about the study and environment. we are talking health care with larry robbins. his outlook on how the pandemic is shaping the future of medical care, and of course the spac merger. as covid infections rise and diving -- dining restrictions return, we will speak to angie mar. we are higher in the markets but not by that much. a little bit of a slow day. the 10-year yield at 85 basis point. crude oil continues to move ahead a little bit. 43. the vix below 23. butterfly networks, the makers of an ultrasound device is going publix to compete with larry fink's spac. founder larryal robbins joins us now. you must be thrilled about the launch on friday, reception of butterfly, though it is a fantastic device. explain what it does. >> it is the first and only to put ultrasound on base -- on a semiconductor chip. it follows the innovation of the doc

a vaccine developed by the university of oxford and astrazeneca prevented a majority of people in a large trial from getting the disease. it stopped an average of 70% from falling ill. that is below the high bar set by pfizer, turner, but effectiveness did rise to above 90% for one of two testing regimes. joe biden plans to name long-term advisor anthony blinken secretary of state. he served as national security advisor and deputy secretary of state. jake sullivan is likely to be named national security advisor. in the u.k., chancellor of the exchequer rishi sunak says he will increase spending this week, trying to shore up the economy in the midst of a resurgence of coronavirus. the focus of the spending would be on the pandemic. plans to assemble key components for google service at the factory. it's facility was unveiled too much fanfare in 2018, but it succumbed to delays and switched directions several times after local officials cut subsidies. global news 24 hours a day, on air and on bloomberg quicktake, powered by more than 2700 journalists and analysts in more than 120 countries.

to distribute these fairly and affordably on coronavirus, that same being developed by the university of oxford in the u.k. has released showing that it's effective against the virus. in 70 percent of cases, the effectiveness of the vaccine was boosted to 90 percent. if patients were given a half dose followed then by a full dose one months later, research is currently unsure why this is. the data also showed no serious safety concerns. it comes as german company, bio on tech and its american partner, pfizer requested emergency use for approval for their vaccine in the us after promising results when i have a look. now, at some other developments in the pandemic, global virus cases that are approaching 60000000 according to a tally by johns hopkins university, the global death toll stands at almost 1400000. china is testing millions of people in imposing local lockdowns. often, multiple new cases were discovered in 3 cities across the country last week, and the united states, germany and the united kingdom ols, say they could begin vaccinations in their countries as soon as december. as now, ta

i'm an ocular for all just at northumbria university says the advantages of the desk virologist at northumbria university says the advantages of the oxfordstrazeneca vaccine are exaggerated. >> to store and transport the major advantage presented. there are no huge other additional advantages. if anything, one can argue the pfizer am bojana vaccines have more advantages. because although in the dust pfizer and bojana vaccine have more advantages -- moderna. it cost 10 times as much to movies around, the freezers consume 10 times as much energy. the fact is we know how to turn these kind of compounds, into powders, and keep them as room temperature stored or plain fridge stored powders. therefore within a year from now it is likely that these companies will be looking to bring to the market, answer the clinic, these ultracold vaccines, but in a powder form that can be stored on a shelf. because of the damage that has been brought by this virus globally, all of the companies are bent to fit -- benefiting to an opportunity to submit to the early use authorization approval. this is a keen double edged sword. because if something happens as t

a vaccine developed by the university of oxford and astrazeneca prevented a majority of people in a trial from getting the disease. it stopped in average of 70% from getting ill. that is below the high bar set by pfizer and moderna. joe biden plans to name a longtime advisor anthony lincoln as secretary -- anthony blinken as secretary of state. he was deputy secretary of state. a former secretary clinton eight is likely to be named national security advisor. the trump i adminstration will tech imports from 87 chinese companies, a move that could escalate tensions as the biden adminstration prepares to. . take over. foxconn will finally stop mass plant -- willa finally start mass production at a plant championed by president trump. the facility was unveiled too much fanfare in 2018, but has encountered delays several times after local officials cut subsidies. global news 24 hours a day, on air and on bloomberg quicktake, powered by more than 2700 journalists and analysts in more than 120 countries. i'm ritika gupta. this is bloomberg. ♪ >> unemployment insurance runs out for many people at

the vaccine was developed at the ukase university of oxford using the a don't know virus platform. researchers took a common cold virus that infects chimpanzees, genetically engineering it to trick the human body into thinking it has been infected with the virus that causes that 19 producing an immune response., over $24000.00 volunteers took part in the clinical trials in the u.k., brazil, and south africa. the late stage trials show the a donor viral vaccine is better at preventing hospitalizations and severe cases of covert 19 than the m.m.r. in a vaccines developed by madonna and pfizer. by on tech, but people are not getting sick with the spike scene, which means that ultimately, even if you were to get ill, you have moral symptoms. and so i think that's incredibly important because it'll keep ospital birds free and people won't be dying from this virus. and that's not the only advantage. unlike the m.r. lay vaccines, it can be kept at normal, frigid temperatures, making it easier to distribute, especially in developing countries. it can also be manufactured at scale, meaning

dow futures up 207 on the positive vaccine news coming from the university of oxford and astrazeneca.course get you more on that as the day goes on we also had positive news on the treatment side out of regeneron getting emergency use authorization for their antibody cocktail treatment there as well so, in the last couple of weeks, we've had three positive vaccine news wells the regeneron and eli lilly treatment news, folks. we are getting there >>> all right. well, during the sub prime mortgage boom when many investors were feverishly and foolishly trading junked up mortgage bonds a few savvy skeptics and some people on air recognized the bonds were doom to fail so they took bets against them and made billions now one of those players is doing the same thing not on sub prime, but on climate change and covid diana olic reports ♪ when we first met dave bert almost a year ago he was working on a thesis and a bet. he calculated that about one third of u.s. homes are over valued because of the rising risks from climate change. >> these hazard events are increasing these costs are increasi

hailed as a vaccine for the world pharmaceuticals firm astra zeneca in partnership with the university of oxford says interim trial results will be sent to regulators immediately in the hope their product is approved for rollout. before the end of the year. we've got a vaccine, which is a fact it prevents a live action intriguingly in result of a headline is that we do have as our are and then have all those of the back. and i guess where we saw 90 percent or more data may be needed to confirm the 90 percent subgroup results, but cheaper to mass produce, easier to distribute, to more moderate temperatures than its competitors. the british vaccine is good news for poorer parts of the world. in time, the astra zeneca oxford vaccine could lead to an end to the pandemic, worldwide reaching parts of the world. the other vaccines on offer simply can't put on a much shorter time scale. it's already being projected by the government here. that vaccine technology may lead to a resumption of normal life by easter for national restrictions in england was the 2nd of december addressing parliament remotely,

they've been promising results from a coronavirus vaccine developed by the university of oxford and astra zeneca. the latest phase 2 findings show a strong immune response has been triggered in people over 70 has more from london . it's just published its phase 2 results, which were based on a group of $560.00 volunteers. these are not its phase 3 results which will be coming in the next few weeks. but the initial results showed that this vaccine is generating a strong immune response, an adult over 1617. this is a very crucial age group because vaccines don't tend to work as well. in older people because as we get older. 'd our immune systems deteriorate. this vaccine is different from the other 2 that we've been reporting on because it is made from a weakened version of the common cold virus found in chimpanzees, which is then modified to make sure that it cannot grow in humans is given in 2 doses. and so far is reporting a 99 percent efficacy rate. all participants have been gently generating neutralizing antibodies. so it is knocking out the virus in their bloodstream with no reported

welcome to our special coverage here on bbc one and bbc news on the day scientists at the university of oxfordt least 70% effective, and will be widely available in the yearahead. the prime minister borisjohnson is about to give a news conference in downing street, to give more details on england's return to the three—tier system when lockdown ends on 2nd december.

drugmaker astra zeneca and the university of oxford in the u.k. say their corona virus vaccine could be up to 90 percent effective in preventing covert 90 all researchers there say the vaccine that was most of active when patients were 1st given a half doz, followed by a full dose one month later, while crucially the new job can be kept at refrigerator temperatures, and does not require extreme cold storage. unlike other recently announced vaccines luster's and a says it will have 200000000 doses available by the end of the year encouraging development there. let's get you more on mohamed, were near joins me now. he's of all interest and vaccine expert at lancaster university in the u.k. . very encouraging news there. dr. murray, near what distinguishes this vaccine from rival vaccines. well, thank you very much for having me on the show. this is certainly very encouraging and more vaccines. we would have acted, would it be because then we've been having choices, but particularly speaking about the last as any cox for the vaccine it has certainly

with me is the infectious disease specialist from the university of oxford, peter drobac, and the 0utbreak95% effective? there are two questions, one, how do you get immunity and how long does immunity last? there are two ways to get immunity, you get infected and recover or get a vaccine and a 95% effective vaccine means the risk of getting symptomatic infections could be reduced to 90%, that still means there is a small chance you could get infected. we don't know yet how com plete get infected. we don't know yet how complete that immunity is and how long it lasts. there have been a few cases where people can get re—unaffected so it is not complete immunity. the big question is going to be does the immunity last six months, one year, two years and the jury months, one year, two years and the jury is still out. peter, how excited are you by this news from the united states about the moderna vaccine? i try not to get excited about scientific news by press release but in this case it's quite exciting. the reason is this, the moderna vaccine and the pfizer vaccines work with similar modaliti

peter droback is an infectious disease and global health expert at university of oxford in england. good to see you. you just heard miguel. obviously the case count has been staggering in the united states. i have to say, unlike the first wave here, there is nowhere to hide in the united states. the issue here, the key metric to look at, is what is going on in hospitals. and what is your worst fear about hospitals right now and what they face in the coming weeks? >> it's grim and it's going to get really, really bad. hospitals are already struggling with the tide of covid-19 patients, on the top of what's always busy in the winter, but they're about to be hit with a tidal wave. the weekend, thanksgiving, is a national superspreader event. millions traveling, gathering households together. all of these little transmission events are going to turbo charge what's happening right now as we approach christmas, we're going to be in a situation where ambulances are driving around trying to find a hospital that can take their patient. doctors are having to make horrible decisions about whic

peter drobak of the university of oxford, i want to thank you for taking us through that step by stepthink it cleared up a lot of issues. >> thank you. >>> europe's most populous country struggling to turn back the tied of coronavirus. germany has topped one million cases of covid-19. it also reported its largest single death toll ever on thursday. >>> meantime, a new report from a u.n. agency says the pandemic has set back the cause of gender equality by years. it says women are disproportionately bearing the brunt of extra work at home. >>> okay. there is a glimmer of hope here in france. the health ministry says a national target of just 5,000 new cases per day could now be reached by mid-december. the nation reported nor than 16,000 new cases on wednesday. with us now is melissa bell. she is life in paris and salma abdelaziz is in london. salma, we will start with you. it will now be avoiding the worst of the lockdown. given everything the uk has gone through, is this really to spare the economy, or does it follow the science? >> well, paula, it sort of depends on what scientists

peter drobac from the university of oxford in england. cine for emergency use authorization from the fda, how excited are you about this? >> well, kim, good to be with you again. a lot of good news not only from the pfizer vaccine and moderna and astrazeneca with the results. that's three vaccines that have shown promising clinical trial results. with the application for the pfizer vaccine, it stills needs to go through, obviously, rigorous scientific review. and it's important that is rigorous, so we can have faith in the results. but if things go well, it is possible there could be an approval of that first vaccine as early as a few weeks from now. >> okay. well, that's obviously, very welcome news. and it can't come soon enough, obviously with cases rising. you know, many here in this country on the left are quick to blame the trump administration for still being mired in the covid crisis, some, you know, nine, ten months after it all started. but you look at europe, where you are, cases are spiking all over the continent there, too. so

or merrill, paul, from the university of oxford, part of dr. paul gans research includes climb richer and its impact on communities . dr. hold on. welcome. what is causing these increasingly devastating storms in the region? yes, thank you very much for having me here today. so a, i think there is a connection. we climate change. why there direct again link has not been get quantify and i think that we've got to have it clear, it's a lot of that as well. a temperature increase, so divorcement temperatures, so yet, and then warmer oceans are expected to aggravate the thanks jenny, but so, so because of storms as we are seeing now. well, i would also like to make it clear that unfortunately the connection between climate change and frequency of a storms is not very strong yet. so when you say that the ocean or waters of warming want to essentially saying, is that stallman's in the future are going to get more powerful? yeah, i did that. that's it. and that's what climate science he's telling us at present. so we have a yeah, we're expected to see

hailed as a vaccine for the world pharmaceuticals firm astra zeneca in partnership with the university of oxford says interim trial results will be sent to regulators immediately in the hope their product is approved for rollout before the end of the year we've got a vaccine which is a fact it prevents a live action intriguingly in result of a headline is that we do have as our are and then have all those of the back. and i guess where we saw 90 percent or more data may be needed to confirm the 90 percent subgroup results, but cheaper to mass produce, easier to distribute, to more moderate temperatures than its competitors. the british vaccine is good news for poorer parts of the world. in time, the astra zeneca oxford vaccine could lead to an end to the pandemic world wide reaching parts of the world. the other vaccines on offer simply can't, but on a much shorter time scale, it's already being projected by the government here. that vaccine technology may lead to a resumption of normal life by easter for national restrictions in england was december addressing parliament remotely while serving

drug maker, astra zeneca and oxford university of announced their vaccine is up to 90 percent effective in preventing covert 19 and the vaccine was most effective when patients were 1st given a half dose followed by a full dose. one months later. crucially, this new vaccine doesn't require extreme cold storage and is relatively cheap and easy to mass produce. these files hold a promising formula for entering the covert 900 pandemic globally. a cheap, effective, easy to distribute that scene. we have to get a lot of people. we're not thinking about solutions working in terms of one person at a time. we have to think about vaccinating communities, populations, reducing transmission within those populations, so that we really get on top of this pandemic. and that's what it now looks like. we're going to have the ability to share in a really big way the vaccine was developed at the ukase university of oxford using the i don't know, virus platform. researchers took a common cold virus that infects chimpanzees, genetically engineering it to trick the human body into thinking it has been infec

meanwhile, the university of oxford says it expects late stage trial results on its covid-19 vaccine by the end of this year. that's raising hopes that britain will start distributing a vaccine by early 2021. >>> still ahead, san jose extends a >>> we're getting a look at how the bay area is reacting to the passing of proposition 22. marco b. saying corporations won again. christy lchltd says good, every driver i talked to wanted this to pass to keep their job in a pandemic. sharon c. responding saying the drivers who want to stay independent contractors are happy and any driver not happy can quit. you can weigh in as well with using the hashtag #kpix. >>> clothing brand gap is getting a lot of mixed reaction today for a tweet regarding the the election. the tweet, which has since been removed shows a half red, half blue hoodie with the caption, one thing we know is together we can move forward. social media divided on this message. one person tweeting, quote, thanks, gap, i'm going to wear this on the battlefield in the civil war to symbolize how we should all be getting along. while

developed by the university of oxford in the uk.nd oxford says it is 70% effective, but that can increase to 90% depending on how it is dosed. joining me nbc news chief foreign correspondent richard engle, who's been following the vaccine since the very beginning. richard, take us through it. >> reporter: so we talked a lot about the oxford vaccine, the astrazeneca vaccine, oxford being the research arm, astrazeneca being the production arm, the corporate sponsor, a lot. it was one of the first ones out of the gate. it was very promising. it was the leader, and then it went quiet a little bit as the american vaccines started to announce their results, announcing exceptional results from pfizer and moderna, with both pfizer and moderna saying they were 95% effective, which is incredibly high. higher than most virologyists could believe. oxford said the vaccine is 70% effective, but with a tweaking of the dose you can get it to 90%. they found much to their surprise that actually if you give people all three of these vaccines or two d

it'seen developing the vaccine with t university of oxford. trazeneca said over 23,000 participants are being assessed, and there were a total of 131 covid-19 cases in the study. in the clinical trials, they adjusted the vaccination dosage and analyzed multiple groups. the company said one regimen showed a vaccine efficacy of 90%, while another showed it was 62% effective. the combined analysis resulted in an average efficacy of 70%. the firm said no hospitalizations or seve cases of the disease were reported. the company said it'll immediately prepare to submit the data to countries that have a framework in place for conditional or early approval. astrazeneca is aiming to have a manufacturing capacity of up to 3 billion doses of the vaccine in 2021. it's made an agreement with the japanese government to provide it with doses. >>> the world health organization's top emergency expert says china has given reassurance that an international field trip to investigate the origins of the coronavirus will happen soon. but no date has been set since the

or merrill pollack don from the university of oxford are part of dr. paul gans research includes climb richer and its impact on communities dr. paul, welcome. what is causing these increasingly devastating storms in the region? yeah, thank you very much for having me here today. so a, i think there is a connection with climate change. why their direct again link has not been get a quantifying. i think that we've got to have it clear. it's a lot of that as well. a temperature increase, so divorcement temperatures, so yet, and then warmer oceans are expected to aggravate the thanks jenny, but so far because of storms as we are seeing now. well, i would also like to make it clear that unfortunately the connection between climate change and frequency of a storms is not very strong yet. so when you say that the ocean or times of warming, want to essentially say news that stallman's in the future are going to get more powerful. yeah, indeed that, that's it. and that's what climate science he's telling us at present. so we have a yeah, we're expected to see t

zeneca has published interim test results for its shop, which is being developed, of course, in conjunction with oxford university. however, as i detail, it's not proving as effective as some of its rivals, astra, zeneca, all the latest company to join the front runners in the covert, 19 vaccine race. and i'll sing an efficacy of 70 percent off the concluding that phase 3 trials. i know these preliminary results may sound humble compared to other vaccines. the company's c.e.o. is optimistic, same as i will be highly effective and will have an immediate impact. and with the u.k. having already preordered 100000000 jobs, boris johnson is more than happy with the result. incredibly exciting news. the oxford vaccine has proved so effective in trials. there are still further safety checks ahead. but these are fantastic results. well done to our brilliant scientists at the university of oxford and astra zeneca and all who volunteered in the trials. so why the relatively low efficacy of developers say that 70 percent figure is an average of 2 dosage. regimens to high doses gave a result of 62 percent with a high dose fo

laura: a vaccine for coronavirus developed at the university of oxford could help across the globe. he vaccine proved highly effective in stopping people fromin devel symptoms of covid-19, results suggesting 70%erotection, by adjusting dose, protection could rise tos as high%, and while others have announced eve higher, the oxford one is cheaper, easier to store,nd easier to deliver around the world. our medical editor,ergus, reports. fergus: for the first time since this wretched virus took hold, c see an end to the pandemic? >> here at oxford. >> a huge, huge congratulations toou. fergus: oxford h created a vaccine not just for britain but for the world. the scientists involved say it normal life. return to >> i can definitely see a future beyond the pandemic. i think we will be able to roll out vaccines next year and have a bighe impac in the u.k., but for humanity, we have to be the world, and that will take a bit to get fers: in le than a year, scientists here have created -- will take a bit. yeaus: in less than a scientists here have created a vaccine. there were thousands of v

astrazeneca and the university of oxford announced their vaccine is safe and is triggering an immuno response in all adults. this is according to preliminary results from a phase two trial that was published in the medical journal. you have pfizer and biontech and they found they are 95% effective. that is higher than initial results suggested. the company's plan is to submit an application for emergency use authorization within days. but those companies and our government still figuring out how to ship tens of millions of doses across the country in what need to be well below zero temperatures. also, how to convince skeptical citizens to take the vaccine. a vast majority would have to be vaccinated to achieve herd immunity. blue ribbon vaccine commission may help ease some of those concerns. >> i would expect that review to be fairly quick and to give up another layer of certainty to the results that have been presented earlier today. >> i don't trust this. and as i say, i'm not a person that likes to take medications anyway. >> i'm not going to take it until what i see what the res

phase two trials with the vaccine is working on with the university of oxford. safe and creates an immune response from the virus. including in older adults over the age of 70. this is important as that age group tend to see the most severe cases of covid-19. and those infections can lead to death. the testing did not assess the vaccine's effectiveness, something the phase three trials should reveal. >>> the progress is much needed. here in california, the state has more than one million cases. nearly 10,000 new covid cases were added. the positivity rate also rising. the seven-day average is 5.3%. >>> health experts say the safest thanksgiving gatherings is the one that you're going to have at home with just the people you live with. but some folks are planning to gather with more friends and family and they're turning to testing to try to ease some of that worry. "today's in the bay" kris sanchez digging deep into the possible strategy. kris? >> well, hi, marcus. this testing site here in campbell is one of 17 testing sites today alone in santa clara county. yo

those groups that are most at risk from the coronavirus working in collaboration with the university of oxford. the vaccine shows a strong immune response in those aged over 70 in its phase 2 trials. it's the 3rd western drug maker to report positive news on the vaccine front. in the last 10 days, even as cases continue to rise. charlie angela reports more good news in the fight, to get corona virus this time from the u.k., after 99 percent of volunteers, given the oxford astra, zeneca vaccine developed antibodies to cope with 19. these are the results from the phase 2 trials using $564.00 in tis result in the largest phase. 3 trials will be published in the next few weeks, but the powerful immune response is generating an adult over 60 is particularly promising as typically vaccines don't work as well. you know, older people, the editor of the scientific journal that reviewed the data, says this vaccine is different to those produced by madonna. and pfizer, by antec, about scenes are based on a technology called m. r.n.a. . this vaccine is different because the spike protein, which provokes t

the university of oxford and astro zenica says their vaccine is 90% effective when people are given half a dose followed by a full dose. the drugmaker says the vaccine does not need to be stored at ultralow temperatures and it will make it easier to distribute. >>> despite a cdc plea not to travel this holiday week, bay area airports are seeing some of the busiest days since march. amber lee reports from oakland international airport where she saw firsthand tonight how busy it was and where people are going. >> reporter: a steady stream of passengers checked in at oakland international airport on monday evening. this week it is expected to be the busiest year since the pandemic. only about half of the [dropped audio ] >> this family is taking a 90 minute flight to las vegas to visit relatives. >> i would be more reluctant to do a long flight. with this you know we are not taking our mask off, not drinking, not eating. >> reporter: others say with all of the cleaning at airports and planes they feel safe and that thanksgiving is about being with family. >> mental health is an issue with p

missions against piracy, samuel romani is a doctoral researcher in international relations at the university of oxford. he explains the strategic significance of a presence in the red sea. the red sea and the horn of africa. important areas because the babble mandates trade is vital for the supply of global energy resources and global oil supplies. 2nd is also a wide range of security threats that come from the region that could go transnational. for example, the role of non-state actors, that is the who it is that maritime shipments or carrier trans national terror attacks in the case of us. so there's a mixture of security and location that is driving great powers to conquer here. well, russia has actually been planning to establish a base for some time. in 2008, putin and moammar gadhafi met which consolidated their foothold in the mediterranean at the time. and right after that, some senior russian military officials discussed building a red sea base in south in yemen, around and then the yemeni civil war shell that the syrian civil war has them to refocus in the mediterranean. over the past coupl